Scientific Leadership Council 2018-11-27T17:37:42+00:00

Scientific Leadership Council

Members of the Scientific Leadership Council (SLC) serve as PHA’s leadership and are cardiologists, pulmonologists and rheumatologists – leading PH experts that branch out into all areas of scientific exploration and treatment of pulmonary hypertension. Not only do they guide the vast array of medical education PHA offers to both the medical and patient communities, they also are involved in the development of cutting edge research exploring various aspects of PH such as the implications of genetics in pulmonary hypertension, treatments for children living with PH, PH and associated diseases and much more.

Many past and present members of the SLC were involved in the creation of the Expert Consensus Document on Pulmonary Hypertension, lead in the development of the Journal Advances in Pulmonary Hypertension and the comprehensive treatment fact sheets and consensus statements available as resources on our website.

The Education Committee provides guidance in the development of patient educational material such as the Patients Survival Guide develops current information on the latest treatments and also develops consensus statements on different aspects of living with pulmonary hypertension.

Mission Statement and Charge

The Education Committee of the Scientific Leadership Council was created to support PHA in its mission to advance PH education in the field for both patient and professional populations. In order to grow the educational opportunities, information and resources available to these communities, the Education Committee is charged with the following activities:

  1. The Education Committee will facilitate education through the development of practice consensus statements and treatment fact sheets
  2. The Education Committee will actively work with the PHPN to develop educational materials.
  3. The Education Committee will support the goals of the PHA Medical Education Fund, including projects for the Online University and in-person CME education events.

The Education Committee will convene periodically to discuss progress, evaluate goals and plan.

Mardi Gomberg-MaitlandM.D., M.Sc. (chair)
Professor of Medicine, VCU School of Medicine
Director of RV Failure, HFpEF, and Cardio-Oncology Programs
Co-Director of the Pulmonary Vascular Disease Program
Inova Heart and Vascular Institute
Falls Church, Va.

Sonja BartolomeM.D.
Director of Liver Transplant Critical Care
Associate Professor, Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Michael J. Cuttica, M.D., M.S.
Associate Professor of Medicine
Northwestern University
Chicago

Jeffrey Fineman, M.D.
Pediatric Critical Care Specialist
Critical Care Division Chief
University of California, San Francisco
Benioff Children’s Hospital
San Francisco

David C. Ishizawar, M.D.
Associate Professor
Froedtert & the Medical College of Wisconsin
Milwaukee

Adolfo Kaplan, M.D.
Associate Director
Pulmonary & Sleep Center of The Valley
McAllen, Texas

Jamie L. W. Kennedy, M.D., FACC
Assistant Professor
Advanced Heart Failure and Transplant Cardiology
Medical Director, Coronary Care Unit and Pulmonary Hypertension Center
University of Virginia
Charlottesville, Va.

John J. Ryan, M.D.
Director, Pulmonary Hypertension Center
University of Utah
Salt Lake City, Utah

Namita SoodM.D.
Associate Professor, Pulmonary, Allergy, Critical Care & Sleep
Ohio State University, Wexner Medical Center
Columbus, Ohio

Corey E. Ventetuolo, M.D., M.S.
Assistant Professor of Medicine and Health Services, Policy, and Practice, The Warren Alpert Medical School of Brown University
Associate Director, Pulmonary Hypertension Center
Medical Director, Adult Extracorporeal Life Support Program
Director of Clinical Research, Pulmonary Division
Rhode Island Hospital
Providence, R.I.

Kimberly Jackson, R.N., chair, PHPN Education Committee
Nurse Cardiovascular Coordinator
University of Kentucky, Gill Heart Institute
Lexington, Ky.

Members of the Research Committees are leading researchers in the field of pulmonary hypertension. They guide the growth and development of PHA’s research program with over $15 million in commited funds for pulmonary hypertension research.

Mission Statement and Charge

The Research Committee of the Scientific Leadership Counsel was created to support PHA in its mission to advance PH research in the field for both patient and professional populations. In order to grow the research opportunities, information and resources available to these communities, the Research Committee is charged with supporting the following activities:

  1. The Research Committee will facilitate knowledge of research, including basic and clinical studies, and their findings to patient and professional communities through PHA’s communication channels, including Pathlight, Advances in Pulmonary Hypertension, the PHA Online University, and PHA Classroom.
  2. The Research Committee will actively reach out to relevant agencies to initiate and strengthen relationships so that there will be opportunities for collaboration to enhance research funds and resources sharing.
  3. The Research Committee will advance the goals of the PHA to become a funding body for new research initiatives.
  4. The Research Committee will encourage the development of new PH research and researchers through mentorship by established research leaders in the field who will recruit and lead newer researchers.

The Research Committee will commence periodically to discuss progress, evaluate goals and plan.

Todd Bull, MD (chair)
Associate Professor of Medicine
University of Colorado
Aurora, Colo.

Eric D. Austin, MD, MSCI
Director, Vanderbilt Pediatric Pulmonary Hypertension Program
Associate Professor of Pediatrics
Vanderbilt University
Nashville, Tenn.

Karen A. Fagan, MD
Associate Professor of Medicine
Chief of Pulmonology, Critical Care
University of South Alabama
Mobile, AL

Matthew R. Lammi, MD
Associate Professor of Medicine
Louisiana State University
New Orleans

Vinicio A. de Jesus Perez, MD
Assistant Professor of Medicine
Stanford University
Stanford, Calif.

PHA’s Advances in Pulmonary Hypertension is the most comprehensive journal on pulmonary hypertension. Content is developed by members of the SLC’s Journal Editorial Board.

Members of the Journal Editorial Board develop the quarterly publication Advances in Pulmonary Hypertension, the most comprehensive journal on pulmonary hypertension with a circulation of over 40,000 pulmonologists, cardiologists and rheumatologists in the U.S. and abroad.

View the full Editorial Advisory Board here.